Company Filing History:
3 out of 14 
1 out of 497 
Years Active: 2020-2024
Title: The Innovative Mind of Daniel Durocher
Introduction
Daniel Durocher, an accomplished inventor based in Toronto, Canada, is renowned for his significant contributions to the field of cancer research. With three patents to his name, his work focuses primarily on therapies for homologous recombination deficient cancers, showcasing his commitment to advancing medical science.
Latest Patents
Durocher's most recent patents have been groundbreaking in their approach to cancer treatment. One notable patent involves the treatment of homologous recombination deficient cancers, which discloses compounds, compositions, uses, and methods employing inhibitors of the CIP2A-TOPBP1 complex. This innovative method targets cancer associated with HR deficiency, utilizing agents that inhibit phosphopeptide recognition of the TOPBP1 BRCT7/8.
In another patent, Daniel explores homologous recombination factors, discussing the influence of these factors on the regulation and monitoring of homologous recombination. This invention opens avenues for screening agents that modulate homologous recombination and methods to activate or enhance this critical process.
Career Highlights
Throughout his career, Daniel has worked with esteemed institutions such as the Sinai Health System and the University of Toronto. His roles in these organizations have significantly contributed to his research and innovations, allowing him to collaborate with leading experts in the field.
Collaborations
Among his notable collaborators are Salomé Adam and Silvia Emma Rossi, both of whom have contributed to the innovative projects that Durocher has spearheaded. Their teamwork exemplifies the synergy found in academic and research institutions, fostering an environment ripe for groundbreaking discoveries.
Conclusion
Daniel Durocher stands out as a leading inventor in the realm of cancer therapy research. His dedication to finding innovative solutions for complex medical challenges, coupled with his successful collaborations, has solidified his reputation as a valuable contributor to the field. As he continues to develop his patents and research, Durocher’s work will undoubtedly inspire future innovations in cancer treatment.